Evidence map›Paper›PMID 25990625›Full record

ArticleHerz2015

Reduction of radiation exposure during ablation of atrial fibrillation.

Ralph Schneider, Jörg Lauschke, Cindy Schneider, Tina Tischer, Aenne Glass, Dietmar Bänsch

Abstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Herz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  4. Article
  5. [Update on radiation exposure in catheter ablation of atrial fibrillation].Herzschrittmachertherapie & Elektrophysiologie · 2020
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ralph SchneiderHeart Centre, University Clinic, University Hospital of Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany. ralph.schneider@med.uni-rostock.de.
Jörg LauschkeHeart Centre, University Clinic, University Hospital of Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany.
Cindy SchneiderHeart Centre, University Clinic, University Hospital of Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany.
Tina TischerHeart Centre, University Clinic, University Hospital of Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany.
Aenne GlassInstitute for Biostatistics and Informatics in Medicine, University Rostock, Rostock, Germany.
Dietmar BänschHeart Centre, University Clinic, University Hospital of Rostock, Ernst-Heydemann-Str. 6, 18057, Rostock, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPulmonary vein isolation (PVI) during ablation of atrial fibrillation (Afib) may be associated with long fluoroscopy duration. Although most current publications report on fluoroscopy time (FT), the dose-area product (DAP) may be a more valuable parameter for depicting radiation exposure. The aim of our study was to describe a method to reduce DAP by simple means during ablation of Afib.

methodsPatients undergoing Afib ablation using a three-dimensional (3D) mapping system were assigned to two fluoroscopy protocols: (1) standard settings with 7.5 pictures/s and collimation to the heart, fluoroscopy as needed for the convenience of the operator (standard group, SG); and (2) strict collimation to the left atrium, a frame rate of 4 pictures/s, shortened pulmonary vein angiography sequences, and maximal orientation by the 3D mapping system (redDAP group). The primary endpoint was DAP.

resultsThe study comprised 206 patients, who were assigned to the SG (n = 101, 49 %) or to the redDAP group (n = 105, 51 %). Mean FT was significantly reduced from 29.9 ± 11.3 min (SG) to 13.3 ± 8.3 min (redDAP group); mean DAP was reduced by approximately 90 % from 8,690 ± 5,727 to 837 ± 647 cGycm(2). The groups did not differ significantly in body mass index (28.8 ± 4.1 vs. 29.0 ± 5.0). PVI could be achieved in 98 of 101 patients (97 %) from the SG group and in all patients (100 %) from the redDAP group. Procedure time was significantly longer in the redDAP group (160.9 ± 35.7 vs. 138.1 ± 34.3 min).

conclusionRadiation exposure during Afib ablation procedures can be reduced with simple means by strict collimation to the left atrium, a frame rate of 4 pictures/s, shortened pulmonary vein angiography sequences, and maximal 3D orientation.

Indexed as

Atrial FibrillationBody Surface Potential MappingCatheter AblationFemaleFluoroscopyHumansImaging, Three-DimensionalMaleMiddle AgedPatient PositioningPhlebographyPulmonary VeinsRadiation ExposureSurgery, Computer-AssistedTreatment OutcomeAtrial fibrillationDose–area productFluoroscopy timeRadiofrequency ablationThree-dimensional electro-anatomical reconstruction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.